Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Toxicology. 2021 Nov 2;464:153016. doi: 10.1016/j.tox.2021.153016

Table 2.

A comprehensive overview of how CBD modulates the secretion of 11 cytokines and chemokines from monocytes activated through extracellular TLRs (3, 7, 8, and 9). Activation columns indicate whether there was a significant difference in cytokine secretion between unstimulated and TLR agonist treated monocytes. CBD effect columns denote whether cytokine production was modulated by CBD treatment, in addition to directionality and concentrations at which significant modulation was observed. (n = 6). Cytokine production below detection is denoted by “−”. Activation columns are denoted by Y (yes) if statistically significant change was observed upon agonist treatment, or N (no). CBD effect columns are denoted by concentrations where CBD produced statistically significant difference, or NE (no effect).

Cytokine IL-4
IL-2
IP-10
IL-1β
TNFα
Treatment Activation CBD effect Activation CBD effect Activation CBD effect Activation CBD effect Activation CBD effect

TLR 3 Y NE Y NE Y ↓5, 10 N NE N NE
TLR 7 Y NE Y NE N NE Y ↓5 Y ↑10
TLR 8 Y NE Y NE Y NE Y ↑10
TLR 9 Y NE N NE Y NE N ↓0.5, 1, 5, 10 Y NE

Cytokine MCP-1
IL-6
IL-10
IL-12p70
IL-8
Treatment Activation CBD effect Activation CBD effect Activation CBD effect Activation CBD effect Activation CBD effect

TLR 3 Y NE N NE N NE Y NE N NE
TLR 7 Y NE Y ↑10 N NE Y NE Y NE
TLR 8 Y NE Y ↓0.5, 1, 5, 10 Y ↑10 Y NE N NE
TLR 9 N NE Y ↓0.5, 1, 5, 10 N NE N NE

Cytokine TGF-β1
Treatment Activation CBD effect

TLR 3 Y NE
TLR 7 Y NE
TLR 8 Y NE
TLR 9 Y ↓0.5, 1